Manuel Modiano
- Oncology top 0.2%
- Cancer Treatment and Pharmacology 20
- Colorectal Cancer Treatments and Studies 14
- Lung Cancer Research Studies 13
- Pancreatic and Hepatic Oncology Research 7
- Cancer Research top 0.5%
-
- Lung Cancer Treatments and Mutations 16
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Epidemiology top 2%
-
- Cancer therapeutics and mechanisms 11
-
- Nausea and vomiting management 9
- Co-authors
- Mace L. RothenbergHoward A. BurrisJohn Sahl AndersenM. Christine CrippsRussell K. PortenoyMalcolm J. MoorePeter G. TarassoffDaniel D. Von Hoff
- Journals
- Journal of Clinical Oncology (34 papers)Investigational New Drugs (5 papers)Cancer (4 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Manuel Modiano
87 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 5.0k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 1.8k
- Hepatology 336
- Epidemiology 1.3k
Countries citing papers authored by Manuel Modiano
This map shows the geographic impact of Manuel Modiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Modiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Modiano more than expected).
Fields of papers citing papers by Manuel Modiano
This network shows the impact of papers produced by Manuel Modiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Modiano. The network helps show where Manuel Modiano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuel Modiano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 7 | |
| 2 | 2015 | 119 | |
| 3 | 2014 | 120 | |
| 4 | 2014 | 8 | |
| 5 | 2013 | 21 | |
| 6 | 2011 | 16 | |
| 7 | 2007 | 23 | |
| 8 | 2006 | 3 | |
| 9 | 2005 | 81 | |
| 10 | 2002 | 24 | |
| 11 | 2002 | 30 | |
| 12 | 2000 | 1 | |
| 13 | 2000 | 15 | |
| 14 | 1998 | 25 | |
| 15 | 1997 | 15 | |
| 16 | 1996 | 21 | |
| 17 | 1996 | 29 | |
| 18 | 1992 | 19 | |
| 19 | 1990 | 17 | |
| 20 | 1990 | 65 |
About Manuel Modiano
Manuel Modiano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 87 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Lung Cancer Research Studies (13 papers), Cancer therapeutics and mechanisms (11 papers), Nausea and vomiting management (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.7k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Manuel Modiano has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mace L. Rothenberg, Howard A. Burris, John Sahl Andersen, M. Christine Cripps, Russell K. Portenoy, Malcolm J. Moore, Peter G. Tarassoff, Daniel D. Von Hoff, Connie Stephens and Ryan Nelson. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.